Sarepta Therapeutics
SRPT
#1630
Rank
ยฃ8.31 B
Marketcap
ยฃ87.04
Share price
-0.78%
Change (1 day)
31.08%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : ยฃ1.88 Billion

According to Sarepta Therapeutics 's latest financial reports the company's total liabilities are ยฃ1.88 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Sarepta Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31ยฃ1.88 B-16.74%
2022-12-31ยฃ2.26 B37.88%
2021-12-31ยฃ1.64 B0.84%
2020-12-31ยฃ1.63 B112.87%
2019-12-31ยฃ0.76 B59.48%
2018-12-31ยฃ0.48 B25.16%
2017-12-31ยฃ0.38 B441.81%
2016-12-31ยฃ70.84 M25.83%
2015-12-31ยฃ56.3 M85.01%
2014-12-31ยฃ30.43 M13.12%
2013-12-31ยฃ26.9 M-46.52%
2012-12-31ยฃ50.3 M234.87%
2011-12-31ยฃ15.02 M-52.47%
2010-12-31ยฃ31.6 M40.53%
2009-12-31ยฃ22.49 M236.24%
2008-12-31ยฃ6.68 M8.43%
2007-12-31ยฃ6.16 M283.53%
2006-12-31ยฃ1.6 M0.95%
2005-12-31ยฃ1.59 M35.99%
2004-12-31ยฃ1.17 M-44.12%
2003-12-31ยฃ2.09 M-34.36%
2002-12-31ยฃ3.19 M41.17%
2001-12-31ยฃ2.26 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ27.99 B 1,387.35%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.78 B-5.40%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.10 B-94.69%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.75 B-59.65%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ3.30 B 75.41%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.29 B 21.76%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.24 B-34.02%๐Ÿ‡บ๐Ÿ‡ธ USA